Hepatitis Monthly

Published by: Kowsar

Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013

Masoumeh Moezzi 1 , Reza Imani 2 , * , Nasser Khosravi 2 , Behrouz Pourheidar 3 , Forouzan Ganji 1 and Ali Karimi 4
Authors Information
1 Department of Community Medicine, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
2 Department of Infectious Diseases, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
3 Central Disease Control Unit, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
4 Department of Microbiology, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
Article information
  • Hepatitis Monthly: May 01, 2014, 14 (5); e17398
  • Published Online: May 3, 2014
  • Article Type: Research Article
  • Received: January 5, 2014
  • Revised: February 15, 2014
  • Accepted: March 24, 2014
  • DOI: 10.5812/hepatmon.17389

To Cite: Moezzi M, Imani R, Khosravi N, Pourheidar B, Ganji F, et al. Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013, Hepat Mon. 2014 ; 14(5):e17398. doi: 10.5812/hepatmon.17389.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol. 2003; 39 Suppl 1-9[PubMed]
  • 2. Pan CQ, Zhang JX. Natural History and Clinical Consequences of Hepatitis B Virus Infection. Int J Med Sci. 2005; 2(1): 36-40[PubMed]
  • 3. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine. 1999; 17(13-14): 1730-3[PubMed]
  • 4. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988; 61(10): 1942-56[PubMed]
  • 5. Zali MR, Kazem M, Farhadi A, Masjedi MR, Zargar A, Nowroozi A. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2(2): 290-8
  • 6. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980; 9(2): 144-8[PubMed]
  • 7. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J. 2000; 6(5-6): 1114-6[PubMed]
  • 8. Merat S, Malekzadeh R, Hoori R, Khatibian M. Hepatitis B in Iran. Arch Iran Med . 2000; 3(4): 192-201
  • 9. Alizadeh AH, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J. 2006; 12(5): 528-37[PubMed]
  • 10. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008; 8(4): 281-94
  • 11. Khosravani A, Sarkari B, Negahban H, Sharifi A, Toori MA, Eilami O. Hepatitis B Infection among high risk population: a seroepidemiological survey in Southwest of Iran. BMC Infect Dis. 2012; 12: 378[DOI][PubMed]
  • 12. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012; 3(11): 770-5[PubMed]
  • 13. Ansari-Moghaddam A, Ostovaneh MR, Sharifi Mood B, Sanei-Moghaddam E, Modabbernia A, Poustchi H. Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study. Hepat Mon. 2012; 12(9)[DOI][PubMed]
  • 14. Salehi M, Alavian SM, Tabatabaei SV, Izadi S, Sanei Moghaddam E, Amini Kafi-Abad S, et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): 283-8[PubMed]
  • 15. Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, et al. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon. 2012; 12(2): 112-7[DOI][PubMed]
  • 16. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine. 2010; 28(3): 623-31[DOI][PubMed]
  • 17. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. Journal of Research in Medical Sciences. 2009; 14(4): 249-58[PubMed]
  • 18. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol. 2003; 38(4): 533-40[PubMed]
  • 19. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 1994; 23(3): 437-55[PubMed]
  • 20. Tavakkoli H, Mir-Nasseri MM, Poustchi H, Afshar P, Motalebi MN, Mohammadkhani A, et al. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002). Hepat Mon. 2008; 8(1): 29-33[DOI][PubMed]
  • 21. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B Prevalence and Risk Factors in Blood Donors in Ghazvin. Hepat Mon. 2005; 5(4): 117-22[DOI][PubMed]
  • 22. Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, et al. Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran. Hepat Mon. 2012; 12(7): 442-7[DOI][PubMed]
  • 23. Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J. 2010; 16 Suppl-23[PubMed]
  • 24. Ting-Lu Z, Zhi-Ping X, Hong-Yu L, Chang-Hong G, Liang Y, Qiang D, et al. A community-based sero-epidemiological study of hepatitis B infection in Lianyungang, China, 2010. Western Pac Surveill Response J. 2012; 3(3): 69-75[DOI][PubMed]
  • 25. Hong WW, Ang LW, Cutter JL, James L, Chew SK, Goh KT. Changing seroprevalence of hepatitis B virus markers of adults in Singapore. Ann Acad Med Singapore. 2010; 39(8): 591-8[PubMed]
  • 26. Ashraf H, Alam NH, Rothermundt C, Brooks A, Bardhan P, Hossain L, et al. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis. 2010; 10: 208[DOI][PubMed]
  • 27. Mikhailov MI, Mamedov MK, Dadasheva AE. [Comparative evaluation of prevalence of infections caused by hepatitis B and C viruses among individuals of various groups with high risk of infection]. Zh Mikrobiol Epidemiol Immunobiol. 2013; (4): 44-8[PubMed]
  • 28. Joukar F, Besharati S, Mirpour H, Mansour-Ghanaei F. Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011; 11(3): 178-81[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments